Pharmacogenomics in Infectious Disease Management explores the genetic factors influencing responses to antimicrobial therapies. It covers the pharmacogenomics of antibiotics, antivirals, and antifungals, highlighting personalized treatment approaches. The book discusses strategies to combat drug resistance and optimize therapy efficacy through genetic insights. Suitable for infectious disease specialists and pharmacogenomic researchers, it enhances the precision of antimicrobial treatments.
Emily Howard applies pharmacogenomics to manage infectious skin diseases, enhancing the efficacy and safety of antimicrobial therapies. Her research focuses on how genetic variations influence patient responses to antibiotics and antifungals used in treating infections like cellulitis and tinea. Emily has published extensively on personalizing antimicrobial treatments through pharmacogenomic testing to improve outcomes and reduce resistance risks. She also provides guidelines for clinicians to utilize pharmacogenomic insights in infectious disease management, promoting effective and personalized dermatological care through genetic-informed antimicrobial strategies